Integrating genomics across drug discovery and development

被引:5
作者
Debouck, Christine [1 ]
机构
[1] Ardennes Biosci LLC, Wayne, PA 19087 USA
关键词
Genomics; Target validation; Disease mechanism; Compound optimization; Biomarkers; Pharmacogenetics; CRITICAL PATH; EXPRESSION SIGNATURES; SYSTEMS BIOLOGY; CANCER; TOXICOGENOMICS; MEDICINE; BIOMARKERS; TOXICITY; RESOURCE; GENETICS;
D O I
10.1016/j.toxlet.2008.09.011
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The sequencing of the human genome was an exceptional achievement, but it was not an end in itself as it set the foundation for building new knowledge in biology and medicine. The laborious, multifaceted science of drug discovery and development also draws tremendous benefits from mining the human genome and exploiting the large palette of genomic technologies. This article discusses how diverse genomic tools have been used to date and how they will continue to be utilized in the future to impact drug discovery and development. Integrating genomics across drug discovery and development will undoubtedly help to shorten timelines, increase success rates at all stages and ultimately bring the right drugs to the right patients at the right times. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:9 / 12
页数:4
相关论文
共 43 条
[1]   Progress and prospects in rat genetics: a community view [J].
Aitman, Timothy J. ;
Critser, John K. ;
Cuppen, Edwin ;
Dominiczak, Anna ;
Fernandez-Suarez, Xose M. ;
Flint, Jonathan ;
Gauguier, Dominique ;
Geurts, Aron M. ;
Gould, Michael ;
Harris, Peter C. ;
Holmdahl, Rikard ;
Hubner, Norbert ;
Izsvak, Zsuzsanna ;
Jacob, Howard J. ;
Kuramoto, Takashi ;
Kwitek, Anne E. ;
Marrone, Anna ;
Mashimo, Tomoji ;
Moreno, Carol ;
Mullins, John ;
Mullins, Linda ;
Olsson, Tomas ;
Pravenec, Michal ;
Riley, Lela ;
Saar, Kathrin ;
Serikawa, Tadao ;
Shull, James D. ;
Szpirer, Claude ;
Twigger, Simon N. ;
Voigt, Birger ;
Worley, Kim .
NATURE GENETICS, 2008, 40 (05) :516-522
[2]   The biomarkers consortium: On the critical path of drug discovery [J].
Altar, C. A. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) :361-364
[3]   A haplotype map of the human genome [J].
Altshuler, D ;
Brooks, LD ;
Chakravarti, A ;
Collins, FS ;
Daly, MJ ;
Donnelly, P ;
Gibbs, RA ;
Belmont, JW ;
Boudreau, A ;
Leal, SM ;
Hardenbol, P ;
Pasternak, S ;
Wheeler, DA ;
Willis, TD ;
Yu, FL ;
Yang, HM ;
Zeng, CQ ;
Gao, Y ;
Hu, HR ;
Hu, WT ;
Li, CH ;
Lin, W ;
Liu, SQ ;
Pan, H ;
Tang, XL ;
Wang, J ;
Wang, W ;
Yu, J ;
Zhang, B ;
Zhang, QR ;
Zhao, HB ;
Zhao, H ;
Zhou, J ;
Gabriel, SB ;
Barry, R ;
Blumenstiel, B ;
Camargo, A ;
Defelice, M ;
Faggart, M ;
Goyette, M ;
Gupta, S ;
Moore, J ;
Nguyen, H ;
Onofrio, RC ;
Parkin, M ;
Roy, J ;
Stahl, E ;
Winchester, E ;
Ziaugra, L ;
Shen, Y .
NATURE, 2005, 437 (7063) :1299-1320
[4]   The eukaryotic genome as an RNA machine [J].
Amaral, Paulo P. ;
Dinger, Marcel E. ;
Mercer, Tim R. ;
Mattick, John S. .
SCIENCE, 2008, 319 (5871) :1787-1789
[5]   The mammalian epigenome [J].
Bernstein, Bradley E. ;
Meissner, Alexander ;
Lander, Eric S. .
CELL, 2007, 128 (04) :669-681
[6]   RNAi technologies: a screen whose time has arrived [J].
Blow, Nathan .
NATURE METHODS, 2008, 5 (04) :361-366
[7]   Structural genomics: inside a protein structure initiative center [J].
Blow, Nathan .
NATURE METHODS, 2008, 5 (02) :203-206
[8]  
Buck Wayne R., 2008, V460, P23, DOI 10.1007/978-1-60327-048-9_2
[9]   Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies [J].
Burczynski, ME ;
Dorner, AJ .
PHARMACOGENOMICS, 2006, 7 (02) :187-202
[10]   Blood gene expression signatures predict exposure levels [J].
Bushel, P. R. ;
Heinloth, A. N. ;
Li, J. ;
Huang, L. ;
Chou, J. W. ;
Boorman, G. A. ;
Malarkey, D. E. ;
Houle, C. D. ;
Ward, S. M. ;
Wilson, R. E. ;
Fannin, R. D. ;
Russo, M. W. ;
Watkins, P. B. ;
Tennant, R. W. ;
Paules, R. S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (46) :18211-18216